1549 related articles for article (PubMed ID: 23767419)
1. Common lung conditions: chronic obstructive pulmonary disease.
Delzell JE
FP Essent; 2013 Jun; 409():23-31. PubMed ID: 23767419
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.
Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ;
Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710
[TBL] [Abstract][Full Text] [Related]
3. Treatment of stable chronic obstructive pulmonary disease: the GOLD guidelines.
Lee H; Kim J; Tagmazyan K
Am Fam Physician; 2013 Nov; 88(10):655-63, 663B-F. PubMed ID: 24364481
[TBL] [Abstract][Full Text] [Related]
4. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
[TBL] [Abstract][Full Text] [Related]
5. [Long-term treatment strategy in chronic obstructive pulmonary disease: how to change the course of the disease].
Devillier P; Salvator H; Roche N; Grassin-Delyle S; Naline E; Dorocant S; Neveu H
Presse Med; 2014 Dec; 43(12 Pt 1):1368-80. PubMed ID: 25455634
[TBL] [Abstract][Full Text] [Related]
6. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
Hanania NA
Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
[TBL] [Abstract][Full Text] [Related]
7. Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting β
Skolnik NS; Nguyen TS; Shrestha A; Ray R; Corbridge TC; Brunton SA
Postgrad Med; 2020 Mar; 132(2):198-205. PubMed ID: 31900019
[TBL] [Abstract][Full Text] [Related]
8. [Inhaled corticosteroid/beta-2 agonist therapy in moderate COPD].
Yıldırım N
Tuberk Toraks; 2010; 58(2):192-201. PubMed ID: 20865575
[TBL] [Abstract][Full Text] [Related]
9. [Medical treatment of COPD].
Vestbo J; Titlestad IL
Ugeskr Laeger; 2013 Apr; 175(18):1261-4. PubMed ID: 23651802
[TBL] [Abstract][Full Text] [Related]
10. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
Ohar JA; Donohue JF
Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
[TBL] [Abstract][Full Text] [Related]
11. [Practice guideline 'Medical treatment of COPD'].
Dekhuijzen PN; Broeders ME; Tuut MK; Grol MH
Ned Tijdschr Geneeskd; 2008 Jun; 152(26):1465-8. PubMed ID: 18666664
[TBL] [Abstract][Full Text] [Related]
12. [Management of patients with stable COPD].
Toyoshima H; Yoshida M
Nihon Rinsho; 2003 Dec; 61(12):2163-9. PubMed ID: 14674327
[TBL] [Abstract][Full Text] [Related]
13. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
Wise RA; Tashkin DP
Am J Med; 2007 Aug; 120(8 Suppl 1):S4-13. PubMed ID: 17678942
[TBL] [Abstract][Full Text] [Related]
14. Innovations to achieve excellence in COPD diagnosis and treatment in primary care.
Fromer L; Barnes T; Garvey C; Ortiz G; Saver DF; Yawn B
Postgrad Med; 2010 Sep; 122(5):150-64. PubMed ID: 20861599
[TBL] [Abstract][Full Text] [Related]
15. Modifying the course of chronic obstructive pulmonary disease: looking beyond the FEV1.
Zuwallack RL; Nici L
COPD; 2012 Dec; 9(6):637-48. PubMed ID: 22958136
[TBL] [Abstract][Full Text] [Related]
16. Guideline for the management of chronic obstructive pulmonary disease (COPD): 2004 revision.
Bateman ED; Feldman C; O'Brien J; Plit M; Joubert JR;
S Afr Med J; 2004 Jul; 94(7 Pt 2):559-75. PubMed ID: 15283307
[TBL] [Abstract][Full Text] [Related]
17. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD).
Cecere LM; Slatore CG; Uman JE; Evans LE; Udris EM; Bryson CL; Au DH
COPD; 2012 Jun; 9(3):251-8. PubMed ID: 22497533
[TBL] [Abstract][Full Text] [Related]
18. Contemporary management of chronic obstructive pulmonary disease: scientific review.
Sin DD; McAlister FA; Man SF; Anthonisen NR
JAMA; 2003 Nov; 290(17):2301-12. PubMed ID: 14600189
[TBL] [Abstract][Full Text] [Related]
19. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
Wurst KE; Shukla A; Muellerova H; Davis KJ
COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
[TBL] [Abstract][Full Text] [Related]
20. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?
Salama RO; Young PM; Rogueda P; Lallement A; Iliev I; Traini D
Expert Opin Pharmacother; 2011 Aug; 12(12):1913-32. PubMed ID: 21714776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
